A phase 3, multicenter, open-label, randomized study of Nab®-Paclitaxel plus Gemcitabine versus Gemcitabine alone as adjuvant therapy in subjects with surgically resected pancreatic adenocarcinoma

Project: Research

Project Description

SERP Reference Number: HREC/14/SVH/66
SSA Reference Number: SSA/14/SHA/30
Monash Health HREC Ref: 14215X
StatusActive
Effective start/end date22/08/1921/08/24

Keywords

  • phase 3 study
  • clinical trial
  • pancreatic cancer
  • treatment efficacy